ScholarX: KIM, CHAN KYO

Detailed Information

KIM, CHAN KYO (김찬교)

Medicine (Medicine)

Research Area

Tel 02-3410-0511
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

MRI:26||Magnetic resonance imaging:19||prostate cancer:16||Cervical cancer:11||Prostate cancer:10||magnetic resonance imaging:9||diffusionweighted imaging:9||renal cell carcinoma:8||Renal cell carcinoma:7||Computed tomography:7||CT:7||computed tomography:7||Diffusionweighted imaging:7||Concurrent chemoradiotherapy:7||Diffusionweighted MRI:6||Apparent diffusion coefficient:6||apparent diffusion coefficient:6||PIRADS:6||radiofrequency ablation:5||Radiofrequency ablation:5||adrenal gland:5||Kidney:5||MR imaging:4||Prostatectomy:4||Biopsy:4||Outcome:4||kidney:3||neoplasm:3||Stage:3||Blood oxygenation leveldependent MRI:3||Disease progression:3||diagnosis:3||diffusionweighted MRI:3||Ultrasound:3||Adenoma:3||rectum:3||PET/CT:3||ultrasound:3||MRIguided biopsy:3||Repeat biopsy:2||Dualenergy CT:2||Urinary bladder neoplasms:2||Prostate biopsy:2||Carcinoma:2||Neoplasm:2||radiomics:2||radiotherapy:2||Radiotherapy:2||Targeted biopsy:2||Prostate neoplasm:2||Prostate neoplasms:2||pheochromocytoma:2||Prostatespecific antigen:2||renal tumor:2||peripheral zone:2||Prostatic neoplasm:2||Prostatic neoplasms:2||Dynamic contrastenhanced MRI:2||highfieldstrength imaging:2||staging:2||Local neoplasm recurrence:2||comparative study:2||Diffusionweighted MR imaging:2||cervical cancer:2||adrenal adenoma:2||carcinoma, renal cell:2||Biomarker:2||transition zone:2||Cancer:2||multiparametric MRI:2||Transrectal ultrasonography:2||Tomography:2||Treatment outcome:2||Prostate:2||prostate neoplasms:2||Ultrasonography:2||Medical image:1||Minimalfat angiomyolipoma:1||Multidetector computed tomography:1||Multiparametric MRI:1||Muscleinvasive:1||Mushroom cap&apos:1||Neoadjuvant chemoradiotherapy:1||Neoadjuvant chemotherapy:1||Neoadjuvant therapy:1||Neoplasm metastasis:1||Nephrectomy:1||Nephronsparing surgery:1||Nivolumab:1||Noncontrast enhanced:1||Opioid:1||Outcomes:1||PET:1||PIRADSv2:1||PRIAS:1||PSMA:1||Parametrial invasion:1||Parametrial involvement:1||Parametrium:1||Partial nephrectomy:1||Pathologic correlation:1||Patient selection:1||Patterns of locoregional recurrence:1||Pelvis:1||Perineural tumor spread:1||Periprostatic neurovascular bundle block:1||Pheochromocytoma:1||Pleuroperitoneal communication:1||Prevalence:1||Prognosis:1||Prognostic factor:1||Prostate ImagingReporting and Data System:1||Prostate canc:1||RCC:1||Radiation dosage:1||Radiation exposure:1||Radical hysterectomy:1||Radical nephrectomy:1||Radical prostatectomy:1||Radiofrequency catheter ablation:1||Renal artery:1||Renal mass:1||Renal neoplasms:1||Repetitive artery and
venous labelling:1||Report:1||Risk factor:1||SRM:1||Segmentation:1||Shear wave elastography:1||Standard technique:1||Submucosal tumor:1||Survey:1||Survival:1||Systematic random biopsy:1||Target biopsy:1||Texture analysis:1||Transplantation:1||Transrectal ultrasound:1||Treatment outcomes:1||Upgrading:1||Urinary tract:1||Urography:1||Urolithiasis:1||Urothelial carcinoma:1||Uterine cervical cancer:1||Uterus:1||Vagina:1||Virtual unenhanced:1||Von Hippel Lindau disease:1||Young?s modulus:1||abdomen:1||ablation:1||active surveillance:1||adenoma:1||adrenal hyperplasia:1||adrenalectomy:1||adrenohepatic fusion:1||adults:1||aldosteronoma:1||androgen deprivation:1||angiomyolipoma:1||apparent diffusion coefficient (ADC):1||biochemical recurrence:1||biomarker:1||biopsy:1||blood oxygenation leveldependent (BOLD) MRI:1||blood oxygenation leveldependent MRI:1||body mass index:1||brain metastases:1||catheter ablation:1||certification:1||clinical interpretation:1||complications:1||computed tomography (CT):1||concurrent chemoradiotherapy:1||confidence interval:1||contrast enhancement:1||cyst:1||cysts:1||deep learning:1||diffusion weighted MRI:1||diffusionweighted MRI (DWI):1||diffusionweighted imaging (DWI):1||dualmodality imaging:1||dynamic contrastenhanced MRI:1||dynamic contrastenhanced magnetic resonance imaging:1||endometrial cancer:1||fallopian tubes:1||followup studies:1||func:1||gammaknife radiosurgery:1||genital:1||gossypiboma:1||growth rate:1||hepatocellular carcinoma:1||high b value:1||highfield MRI:1||highfield magnetic resonance imaging:1||highintensity focused ultrasonic ablation:1||histologic grade:1||hypoxia:1||imageguided biopsy:1||immune checkpoint inhibitors:1||immunotherapy:1||liver cirrhosis:1||localized prostate cancer:1||machine learning:1||magnetic resonance:1||magnetic resonance ima:1||magnetic resonance spectroscopy:1||magnetic resonance, contrast enhancement:1||magnetic resonance, tissue characterization:1||metastasis:1||mortality:1||mpMRI:1||multicenter study:1||multidetector row computed tomography:1||natural history:1||neoplasm grading:1||neoplasm metastasis, local:1||neoplasms:1||nephroureterectomy:1||outcome:1||ovarian highgrade serous carcinoma:1||ovarian neoplasms:1||ovary MRI:1||ovary PET:1||ovary neoplasm:1||overall survival:1||pelvic mass:1||pelvis:1||platinum sensitivity:1||prediction:1||preoperative staging:1||prostate:1||prostate biopsy:1||prostate carcinoma:1||prostate gland:1||prostate health index density:1||prostate multiparametric MRI:1||prostate neoplasm:1||prostate neoplasm, magnetic resonance:1||prostatespecific antigen:1||prostatespecific antigen density:1||prostatectomy:1||radical hysterectomy:1||radical prostatectomy:1||radiofrequency:1||recurrence:1||recurrent ovarian tumor:1||rena:1||renal function:1||reproductive:1||sign:1||small renal mass:1||spiral computed:1||stage IB1:1||sunitinib:1||surgery complications:1||survival:1||survival prediction:1||target biopsy:1||tomography, xray computed:1||transhepatic radiofrequency ablation:1||transitional cell:1||treatment failure:1||urethra:1||urothelial carcinoma:1||uterine cervical neoplasms:1||von:1||&apos:1||von HippelLindau disease:1||":1||3 Tesla:1||3T MRI:1||Active surveillance:1||Adjuvant radiotherapy:1||Adrenal:1||Adrenal gland:1||Adrenal glands:1||Adrenocortex:1||Adrenocortical carcinoma:1||Adrenocortical tumor:1||Anticoagulant:1||Antimicrobial prophylaxis:1||Antiplatelet:1||BMI:1||Biopsy core:1||Biopsy needle:1||Bladder:1||Bladder cancer:1||Blood oxygenation leveldependent:1||CI:1||Chronic renal failure:1||Comparative study:1||Complication:1||Computed tomogra:1||Concurrent chemorad:1||Continuous ambulatory peritoneal dialysis:1||Contrast media:1||Contrastenhanced computed tomography:1||Contrastinduced nephropathy:1||DWI:1||Deep learning:1||Deep rectosigmoid endometriosis:1||Diffusionweighted imaging:1||Double dose reduction:1||Dynamic contrastenhanced MR imaging:1||Endometrial cancer:1||Endometrial neoplasms:1||Enema:1||Exponential apparent diffusion coefficient:1||F18FDG PET/CT:1||FIGO:1||Fully convolutional neural network:1||Fusion:1||Gadobutrol:1||Gleason score:1||Grade:1||Hepatic tumor:1||Hepatocyte:1||Hydrothorax:1||Hypoxia:1||Hysterectomy:1||IMDC poorrisk:1||ImageGuided Biopsy:1||Imageguided biopsy:1||Immunotherapy:1||Indexterms Female:1||Inferior vena cava:1||International Federation of Gynecology and Obstetrics:1||Intrarectal lidocaine gel application:1||Iodine overlay technique:1||Kidney disease:1||Kidney tumor:1||Local anesthesia:1||Locoregional recurrence:1||Low dose:1||Lumbosacral plexopathy:1||Lymph nodes:1||Lymphangioma:1||Lymphatic metastasis:1||MDCT:1||Magnetic Resonance Imaging:1||Magnetic resonance angiography:1||Magnetic resonance imaging, Positron emission tomography:1||Malignancy:1||

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE